Sisram Medical Ltd

SEHK:1696 Voorraadrapport

Marktkapitalisatie: HK$1.5b

Sisram Medical Toekomstige groei

Future criteriumcontroles 4/6

Er wordt voorspeld dat Sisram Medical de winst en omzet met respectievelijk 26.5% en 12.8% per jaar zal laten groeien.

Belangrijke informatie

26.5%

Groei van de winst

n/a

Groei van de winst per aandeel

Medical Equipment winstgroei39.9%
Inkomstengroei12.8%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt15 Nov 2024

Recente toekomstige groei-updates

Recent updates

What Sisram Medical Ltd's (HKG:1696) 40% Share Price Gain Is Not Telling You

Oct 07
What Sisram Medical Ltd's (HKG:1696) 40% Share Price Gain Is Not Telling You

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Aug 23
Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Jul 24
Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Jun 17
Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Apr 21
Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Mar 28
Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Mar 05
Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Jan 23
Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Dec 29
Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Nov 09
Is Sisram Medical (HKG:1696) Using Too Much Debt?

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Oct 19
Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

Sep 18
At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Aug 14
Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Jun 16
Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

May 30
Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Apr 19
Is Sisram Medical (HKG:1696) Using Too Much Debt?

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Mar 01
Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Jan 12
Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Dec 21
Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Dec 01
Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Oct 14
Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Sep 28
Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Aug 25
These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Aug 01
Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

May 19
These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

May 03
Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Apr 11
If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Mar 17
Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Nov 22
Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Aug 22
Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Jul 27
Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

Jun 24
Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

Winst- en omzetgroeiprognoses

SEHK:1696 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202649548N/AN/A1
12/31/202543340N/A263
12/31/202438433N/A233
6/30/2024356243340N/A
3/31/2024358283442N/A
12/31/2023359313544N/A
9/30/202335535-532N/A
6/30/202335238-4619N/A
3/31/202335339-4421N/A
12/31/202235440-4222N/A
9/30/202234938-1122N/A
6/30/2022344351922N/A
3/31/2022319332427N/A
12/31/2021294312932N/A
9/30/2021255283540N/A
6/30/2021216244247N/A
3/31/2021189192936N/A
12/31/2020162131626N/A
9/30/2020161131019N/A
6/30/202016013412N/A
3/31/2020167171117N/A
12/31/2019174211821N/A
9/30/2019167221921N/A
6/30/2019161241922N/A
3/31/2019158231719N/A
12/31/2018154221516N/A
9/30/2018151181314N/A
6/30/2018149141011N/A
3/31/201814312N/A14N/A
12/31/201713711N/A17N/A
9/30/201713111N/A18N/A
6/30/201712610N/A19N/A
3/31/201712311N/A20N/A
12/31/20161188N/A16N/A
12/31/20151108N/A16N/A
12/31/20141016N/A23N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei 1696 ( 26.5% per jaar) ligt boven de spaarquote ( 2.3% ).

Winst versus markt: De winst van 1696 ( 26.5% per jaar) zal naar verwachting sneller groeien dan de Hong Kong markt ( 11.6% per jaar).

Hoge groeiwinsten: De winst van 1696 zal naar verwachting de komende 3 jaar aanzienlijk groeien.

Omzet versus markt: De omzet van 1696 ( 12.8% per jaar) zal naar verwachting sneller groeien dan de markt Hong Kong ( 7.8% per jaar).

Hoge groei-inkomsten: De omzet van 1696 ( 12.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van 1696 naar verwachting over 3 jaar hoog zal zijn


Ontdek groeibedrijven